Retraction Note: Mesenchymal stem cell-derived exosome miR-542-3p suppresses inflammation and prevents cerebral infarction
- PMID: 36647168
- PMCID: PMC9843965
- DOI: 10.1186/s13287-022-03227-x
Retraction Note: Mesenchymal stem cell-derived exosome miR-542-3p suppresses inflammation and prevents cerebral infarction
Retraction of
-
Mesenchymal stem cell-derived exosome miR-542-3p suppresses inflammation and prevents cerebral infarction.Stem Cell Res Ther. 2021 Jan 6;12(1):2. doi: 10.1186/s13287-020-02030-w. Stem Cell Res Ther. 2021. Retraction in: Stem Cell Res Ther. 2023 Jan 16;14(1):9. doi: 10.1186/s13287-022-03227-x. PMID: 33407827 Free PMC article. Retracted.
Similar articles
-
Mesenchymal stem cell-derived exosome miR-542-3p suppresses inflammation and prevents cerebral infarction.Stem Cell Res Ther. 2021 Jan 6;12(1):2. doi: 10.1186/s13287-020-02030-w. Stem Cell Res Ther. 2021. Retraction in: Stem Cell Res Ther. 2023 Jan 16;14(1):9. doi: 10.1186/s13287-022-03227-x. PMID: 33407827 Free PMC article. Retracted.
-
Bone mesenchymal stem cell-derived exosomal microRNA-29b-3p prevents hypoxic-ischemic injury in rat brain by activating the PTEN-mediated Akt signaling pathway.J Neuroinflammation. 2020 Feb 3;17(1):46. doi: 10.1186/s12974-020-1725-8. J Neuroinflammation. 2020. Retraction in: J Neuroinflammation. 2020 Nov 23;17(1):352. doi: 10.1186/s12974-020-02034-6. PMID: 32014002 Free PMC article. Retracted.
-
Mesenchymal Stem Cell-Derived Exosomes Improved Cerebral Infarction via Transferring miR-23a-3p to Activate Microglia.Neuromolecular Med. 2022 Sep;24(3):290-298. doi: 10.1007/s12017-021-08686-8. Epub 2022 Jan 10. Neuromolecular Med. 2022. PMID: 35001328
-
Exosomal LncRNA-NEAT1 derived from MIF-treated mesenchymal stem cells protected against doxorubicin-induced cardiac senescence through sponging miR-221-3p.J Nanobiotechnology. 2020 Oct 31;18(1):157. doi: 10.1186/s12951-020-00716-0. J Nanobiotechnology. 2020. PMID: 33129330 Free PMC article.
-
Mesenchymal stem cells-derived exosomal miR-24-3p ameliorates non-alcohol fatty liver disease by targeting Keap-1.Biochem Biophys Res Commun. 2022 Dec 31;637:331-340. doi: 10.1016/j.bbrc.2022.11.012. Epub 2022 Nov 11. Biochem Biophys Res Commun. 2022. PMID: 36423379
References
Publication types
LinkOut - more resources
Full Text Sources